Bicycle Therapeutics: Trading Below Cash Amid Multiple Uncertainties
Source: SeekingAlpha
2026-06-01 02:59:04 ET
Editor's note: Seeking Alpha is proud to welcome Haolin Yin as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » ...
Read the full article on Seeking Alpha
For further details see:
Bicycle Therapeutics: Trading Below Cash Amid Multiple Uncertainties
Bicycle Therapeutics plc
NASDAQ: BCYC
BCYC Trading
-2.45% G/L:
$4.18 Last:
221,059 Volume:
$4.28 Open:
BCYC Latest News
May 21, 2026 05:00:00 pm
Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
April 30, 2026 07:00:00 am
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
April 21, 2026 10:31:00 am
Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting
BCYC Stock Data
$390,541,254
48,834,999
1.84%
42
N/A
Biotechnology & Life Sciences
Healthcare
GB
Cambridge
